ESC 365 - Primary endpoint is negative, what next? A clinical perspective.

ESC Premium Access

Primary endpoint is negative, what next? A clinical perspective.

Session: Interpreting clinical trials: does a primary endpoint tell it all?

Topic: Drug therapy

Speaker: Professor M. Pfeffer (Boston, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Marc Pfeffer

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

27 presentations

1 follower

3 more presentations in this session

Primary endpoint is negative, what next? A statistical perspective.

Speaker: Professor S. Pocock (London, GB)

Primary endpoint is positive, is that enough? A clinical perspective.

Speaker: Doctor G. Stone (New York, US)

Primary endpoint is positive, is that enough? A statistical perspective.

Speaker: Professor P. Juni (Oxford, GB)

Access the full session

Interpreting clinical trials: does a primary endpoint tell it all?

Speakers: Professor M. Pfeffer, Professor S. Pocock, Doctor G. Stone, Professor P. Juni

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources